.
MergerLinks Header Logo

Announced

Alliance Pharma completed the acquisition of Biogix for $110m.

Financials

Edit Data
Transaction Value£82m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Cross Border

Completed

Acquisition

consumer healthcare

United States

Majority

Health Care Services

Friendly

Private

Single Bidder

Synopsis

Edit

Alliance Pharma, an international healthcare group, completed the acquisition of Biogix, the US-based consumer healthcare company, for $110m. "As 2020 draws to a close, I am very pleased to be announcing the successful completion of the Biogix acquisition, a substantial and strategically important acquisition for Alliance, which increases our presence in the US and in consumer healthcare. As an established, clinically evidenced brand with significant sales and good growth potential, in a growing market, Amberen fits perfectly with our strategy of acquiring established consumer healthcare brands in territories where we already have a presence," Peter Butterfield, Alliance Chief Executive Officer.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US